The landmark 2017 Cell study (Baar MP et al., PMID: 28340339) demonstrated that: (1) FOXO4 protein specifically accumulates in senescent cells where it binds to p53 and prevents p53 from triggering apoptosis (this is the specific mechanism being targeted)
Phytotherapy Research, 33 (6), 16271638
This method should only be performed under medical supervision
My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides
"Our goal is to expand the solutions we offer to consumers with diverse skin concerns and to strengthen our competitiveness across major global markets, including the United States." About Beauty Bridge, Inc
This article is for general information and is not medical advice